Bio-Rad Laboratories, Inc. (BIO) vs Universal Health Services, Inc. (UHS)
A side-by-side comparison of Bio-Rad Laboratories, Inc. and Universal Health Services, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 11, 2026. Differences are shown without an overall score or investment verdict.
BIO
Bio-Rad Laboratories, Inc.
$356.35HealthcareDelayed quote: Aug 11, 2026, 3:59 PM EDT
UHS
Universal Health Services, Inc.
$168.72HealthcareDelayed quote: Aug 11, 2026, 3:59 PM EDT
Total return — BIO vs UHS
growth of $100 · dividends reinvested · last 10yBIO +131.5% (+8.8%/yr)UHS +43.0% (+3.6%/yr)BIO compounded faster over this window
BIO UHS
BIO vs UHS: by the numbers
- •UHS is the larger company ($10.21B vs $9.59B market cap).
- •UHS trades at the lower trailing earnings multiple (7.09 vs 42.97 P/E), one valuation lens rather than an overall verdict.
- •BIO converts more revenue to profit (8.59% vs 8.42% net margin).
- •UHS grew revenue faster over the past five years (8.21% vs 0.29% CAGR).
- •UHS pays a dividend (0.46% yield), while BIO has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | BIO | UHS |
|---|---|---|
| P/E ratio | 42.97 | 7.09 |
| Forward P/E | 36.77 | 7.63 |
| P/S ratio | 3.67 | 0.57 |
| P/B ratio | 1.33 | 1.38 |
| EV / EBITDA | 26.74 | 5.73 |
| FCF yield | 3.71% | 7.99% |
Profitability
| Metric | BIO | UHS |
|---|---|---|
| Gross margin | 51.90% | 90.69% |
| Operating margin | 9.08% | 11.36% |
| Net margin | 8.59% | 8.42% |
| ROE | 3.10% | 20.31% |
| ROIC | 2.04% | 11.29% |
Dividends
| Metric | BIO | UHS |
|---|---|---|
| Dividend yield | N/A | 0.46% |
| Payout ratio | N/A | 3.42% |
Growth (annualized)
| Metric | BIO | UHS |
|---|---|---|
| Revenue CAGR (5Y) | 0.29% | 8.21% |
| EPS CAGR (5Y) | -26.27% | 16.19% |
| FCF CAGR (5Y) | -9.65% | -12.18% |
| Total return CAGR (5Y) | -14.23% | 3.81% |
Frequently asked
- Which has the lower trailing P/E, BIO or UHS?
- UHS has the lower trailing P/E: BIO trades at 42.97 and UHS at 7.09. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, BIO or UHS?
- Over the past five years, UHS grew revenue faster — BIO at a 0.29% CAGR versus UHS at 8.21%.
- Does BIO or UHS pay a bigger dividend?
- UHS pays a dividend (0.46% yield), while BIO has no payments in the available dividend history.
- Is BIO or UHS more profitable?
- BIO runs the higher net margin — BIO at 8.59% versus UHS at 8.42%.
- How have BIO and UHS total returns compared?
- Over the past 10 years, BIO delivered 8.69% and UHS delivered 3.63% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Bio-Rad Laboratories P/E ratioUniversal Health Services P/E ratioUniversal Health Services dividend yieldBio-Rad Laboratories ROEUniversal Health Services ROEBio-Rad Laboratories operating marginUniversal Health Services operating marginBio-Rad Laboratories revenue growthUniversal Health Services revenue growthBio-Rad Laboratories free cash flowUniversal Health Services free cash flow
Bio-Rad Laboratories & Universal Health Services appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 11, 2026.